-
461
Prediction of miRNA-circRNA Associations Based on k-NN Multi-Label with Random Walk Restart on a Heterogeneous Network
Published 2019-12-01Subjects: Get full text
Article -
462
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
Published 2019-06-01“…Our study combines two promising clinical methodologies—conditioning/dose-extension and open-label placebo—to investigate whether placebo effects can increase the effective potency of methadone in treatment-seeking OUD patients.Methods and analysis A total of 120 newly enrolled treatment-seeking OUD patients will be randomly assigned to one of two different groups: either methadone plus daily placebo dose-extension (PDE; treatment group) or methadone/treatment as usual (control). …”
Get full text
Article -
463
Image-Based Analysis of Tumor Localization After Intra-Arterial Delivery of Technetium-99m-Labeled SPIO Using SPECT/CT and MRI
Published 2017-01-01“…The aim of this study is to evaluate the localization of 99m Tc-labeled dextran-coated superparamagnetic iron oxide (SPIO) nanoparticles to the liver tumor using image-based analysis. …”
Get full text
Article -
464
Le label « Ville et Pays d’art et d’histoire » en France : une double opérativité symbolique du patrimoine
Published 2016-09-01Get full text
Article -
465
In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer
Published 2022-01-01“…This study evaluates the distribution and therapeutic efficacy of radioiodine-labeled pHLIP variant 3 (Var3) in a mouse model of BC. …”
Get full text
Article -
466
Influence of label and academic field on cancer stigma and subjective illness theories among medicine and psychology students: a cross-sectional online study
Published 2025-01-01“…Medicine students endorsed more stigmatizing statements with the label “cancer survivors,” while psychology students did so with the label “persons with cancer.” …”
Get full text
Article -
467
Penerapan Library AR.js pada Aplikasi e-Label Batik untuk Mendukung Kejelasan dan Kecepatan Tampilnya Informasi Keaslian Batik
Published 2019-05-01Subjects: Get full text
Article -
468
EXtending Omalizumab Treatment Intervals in patients with Chronic spontaneous urticaria (EXOTIC): protocol of a multicentre, randomised, open-label, non-inferiority trial
Published 2025-01-01“…Here, we present the rationale and design of the EXtending Omalizumab Treatment Intervals in patients with Chronic spontaneous urticaria trial, a multicentre, randomised, open-label, non-inferiority clinical trial. The objective of this trial is to investigate if patients with well-controlled CSU, achieved by standard treatment of 300 mg omalizumab administered subcutaneously every 4 weeks (Q4W) for 12 weeks, can maintain disease control with every 6 weeks (Q6W) dosing interval.Methods and analysis Participants who achieve an Urticaria Control Test (UCT) score ≥12 after 12 weeks on omalizumab will be randomised to 300 mg omalizumab treatment Q4W or Q6W. …”
Get full text
Article -
469
99mTc(CO)3-Labeled 1-(3-Nitropyridin-2-yl) Piperazine as Potential Radioligand for 5-HT7 Receptors
Published 2024-12-01Get full text
Article -
470
-
471
-
472
Noninvasive Optical Imaging and In Vivo Cell Tracking of Indocyanine Green Labeled Human Stem Cells Transplanted at Superficial or In-Depth Tissue of SCID Mice
Published 2015-01-01“…In this study, we have optimized the ICG labelling conditions that is optimal for noninvasive optical imaging and demonstrated that ICG labelled cells can be successfully used for in vivo cell tracking applications in SCID mice injury models.…”
Get full text
Article -
473
-
474
-
475
-
476
China’s carbon labeling legal system and green supply chain management from the perspective of sustainability: status quo, implementation problems and legislative recommendations
Published 2025-12-01Subjects: “…Carbon labeling system…”
Get full text
Article -
477
Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial
Published 2022-06-01“…The intervention will be evaluated in a monocentric, open-label, pragmatic, two-arm randomised controlled trial with a sample ratio of 1:1 and a parallel design. …”
Get full text
Article -
478
-
479
-
480